BioSpace News Archive

Business

ClearPoint Neuro Reports First Quarter 2022 Results

ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced financial results for its first quarter ended March 31, 2022.

May 11, 2022
·
10 min read
Business

Femasys Inc. Announces Financial Results for the First Quarter Ended March 31, 2022

Femasys Inc. (NASDAQ: FEMY), a biomedical company aiming to meet women’s needs worldwide by developing a suite of product candidates that include minimally invasive, in-office technologies for reproductive health, today announced financial results for the first quarter ended March 31, 2022.

May 11, 2022
·
10 min read
Biotech Beach

Viracta Therapeutics to Present at Upcoming May 2022 Investor Conferences

Viracta Therapeutics, Inc., a precision oncology company targeting virus-associated malignancies, announced that company management will present and participate in one-on-one meetings at the following investor conferences in May.

May 11, 2022
·
1 min read
Business

Oncocyte Reports First Quarter 2022 Financial Results

Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company with the mission to improve patient outcomes by providing personalized insights that inform critical decisions throughout the patient care journey, today reports financial results for the first quarter 2022, ended March 31, 2022.

May 11, 2022
·
12 min read
Business

Walter Charles Named Senior Vice President and General Manager of CSL Plasma

Walter Charles has been named Senior Vice President and General Manager of CSL Plasma, effective 1 May.

May 11, 2022
·
3 min read
Business

Acorda Therapeutics and Biopas Laboratories Announce Agreement to Commercialize INBRIJA® in Latin America

Acorda Therapeutics, Inc. (Nasdaq: ACOR) and Biopas Laboratories today announced that they have entered into distribution and supply agreements to commercialize INBRIJA® in Latin America.

May 11, 2022
·
6 min read
Genetown

Eyevensys Recaps Highlights from Investigator Meeting and Presentations at the ARVO 2022 Annual Conference

Eyevensys, a privately held, clinical-stage biotechnology company developing non-viral gene therapies for ophthalmic diseases, today provided highlights from the Association for Research in Vision and Ophthalmology (ARVO) 2022 Annual Conference held in Denver, Colorado.

May 11, 2022
·
5 min read
OSE Immunotherapeutics To Present at ‘Immuno-Oncology Summit Europe’ and at ‘Tumor Myeloid-Directed Therapies Summit’ In London and Boston

OSE Immunotherapeutics SA has been invited to provide an update on its R&D programs in immuno-oncology at two dedicated international conferences in May and June.

May 11, 2022
·
6 min read
Report from the Annual General Meeting of IRLAB Therapeutics AB

IRLAB Therapeutics AB’s Annual General Meeting 2022 was held, Wednesday May 11, 2022, at Wallenbergs Konferenscentrum, Medicinaregatan 10 A in Göteborg.

May 11, 2022
·
5 min read
Business

IceCure Medical to Report Q1 2022 Results and Conduct Conference Call May 18, 2022

IceCure Medical Ltd. (NASDAQ: ICCM) (TASE: ICCM) (“IceCure” or the “Company”), today announced it will report its business and financial results for the first quarter ended March 31, 2022 on Wednesday, May 18, 2022 with a press release issued at 7:00 am ET.

May 11, 2022
·
2 min read